Nigeria Health Watch
Follow us:
breadcrumb banner

Nigeria’s New Malaria Plan Must Turn Progress into Protection

Blog Image
By Sunday Oko | November 19, 2026

In 2010, more than four in every ten Nigerian children under five carried malaria parasites. Today, about one in seven do. That was the headline of the 2025 Nigeria Malaria Indicator Survey (NMIS), whose final report was launched alongside the National Malaria Strategic Plan (NMSP) 2026–2030. Yet Nigeria still carries the world’s heaviest malaria burden, with 24.3% of global malaria cases and 30.3% of malaria deaths, according to the World Malaria Report 2025.

The NMSP is Nigeria’s five-year roadmap for malaria control, setting targets, interventions, budget, and an accountability framework for the National Malaria Elimination Programme (NMEP), states, and partners. The 2026–2030 plan, the country’s sixth, is hinged on subnational tailoring (SNT): using local data to match the mix of interventions to each state and local government area. It is anchored in the Health Sector Strategic Blueprint, the Sector-Wide Approach and the WHO Global Technical Strategy for Malaria.

Unveiling of the 2026 Nigeria Malaria Indicator Survey (NMIS) Report and the National Malaria Strategic Plan 2026–2030 at the official launch by the National Malaria Elimination Programme, Federal Ministry of Health and Social Welfare, Abuja. Image credit: Nigeria Health Watch

At the launch of the Nigeria Malaria Indicator Survey (NMIS) report held in September 2026, the NMEP set out what it expects next: states committing to costed plans tied to the survey’s transmission strata, public financing commitments with a strategy to close resource gaps, and agreed roles, indicators and a review cycle to 2030. It all arrives as donor funding shrinks, which raises a hard question. Can a plan written in leaner times turn hard-won progress into lasting protection for every household?

What the survey shows

Malaria prevalence among children aged 6–59 months fell to 15% in 2025, from 22% in 2021, the largest drop since 2015. It was measured at the peak of the transmission season, so it is not a flattering snapshot. Kebbi fell from 49% to 18%, and no state is now in WHO’s high-transmission stratum.

The progress is uneven. Prevalence ranges from 2.6% in Lagos to 31% in Ebonyi, and rural children are more than twice as likely to be infected as urban children (20% against 8%).

Prevention coverage, meanwhile, barely moved:

Source: Comparative analysis of the 2021 NMIS Key Indicators Report, the 2021 NMIS fact sheet and the 2025 NMIS Key Indicators Report

What the new plan commits to

The NMSP 2026–2030 aims to halve malaria prevalence and deaths from 2025 levels by 2030, at a cost of ₦6.48 trillion (about US$4.3 billion).

Source: NMIS 2025 Report

Beyond nets, the toolbox widens to dual-active-ingredient ITNs, targeted spraying, larval source management, house screening and a wider rollout of the R21 malaria vaccine.

Prevention takes more than 75% of the budget. Financing is meant to come increasingly from federal and state budgets, health insurance and a pooled National Malaria Financing Facility.

What this means for malaria prevention

The central challenge is a coverage gap. The plan asks for child net use to rise from 45% to 75% by 2030, and IPTp3 from 33% to 75%, after four years in which both barely moved.

With 79% of household nets coming from mass campaigns, coverage rises and decays in cycles. Antenatal clinics, immunisation visits and schools must carry far more continuous distribution, alongside efforts to get nets used: 15% went unused.

Fifty-five per cent of recent mothers had four or more antenatal visits, yet only 33% received three doses of sulfadoxine-pyrimethamine (SP). Reliable SP stock and community delivery would close much of that gap.

Prevention must extend beyond the bed net.

Insecticide resistance and the invasive urban mosquito Anopheles stephensi, now detected in neighbouring Niger, make larval source management, sanitation and house screening central, not experimental.

Tailoring must reach the states that need it most.

SNT is not new, as Nigeria introduced it in 2019. Research by the Exemplars in Global Health programme found that it made malaria programming more efficient and more responsive to local needs. It also found weak data quality, a heavy reliance on technical partners for modelling, and unreliable financing, which has led to partial rollouts and interrupted campaigns.

Ebonyi’s rise to 31% shows what happens when interventions slip. Tailoring must mean sharper targeting of the hardest-hit areas, not thinner coverage.

Domestic money will decide the outcome.

Reaching 60% domestic financing depends on states budgeting for malaria and releasing the funds, a delivery test Nigeria Health Watch has highlighted before. The SNT research recommends building tailoring into annual planning and budgeting cycles, which would strengthen that investment case.

Communities need to move from knowing to doing.

Eighty-eight per cent of women know malaria is preventable, but only 55% heard a malaria message in the past six months. Messaging should run through trusted networks and community health workers, and tackle misinformation about the vaccine.

From plan to protection

Nigeria now has the evidence and the plan. What decides the outcome is follow-through.

States should translate the national plan into operational plans that align with their own survey data, and governments must release the funds, moving towards at least 60% of malaria resources coming from domestic sources. Every antenatal visit should protect a pregnancy: 55% of mothers had four or more visits in 2025, yet only 33% received three doses of sulfadoxine-pyrimethamine (SP). Every child needs a net: only 45% of under-fives slept under one.

Civil society, the media and communities should track the plan’s targets and keep malaria on the public agenda. A strategic plan is a promise. The next Nigeria Malaria Indicator Survey will show whether Nigeria kept it.

SHARE:

Leave a Comment

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.